Latest Dynasil Corporation of America (DYSL)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Dynasil Corporation of America (DYSL) Headlines

Why Dynasil Corporation (DYSL) Exploded on Monday
at The Street - Mon Feb 24, 10:10AM CST
Shares of Dynasil Corporation of America (DYSL) explode on Monday after the company announced its subsidiary Optometrics Corporation had signed a three-year comprehensive supply agreement with a division of L-3 Communications.

Dynasil's Optometrics Subsidiary Signs Three-Year Comprehensive Supply Agreement with a Division of L-3 Communications
PR Newswire - Mon Feb 24, 8:15AM CST
Dynasil Corporation of America (NASDAQ: DYSL) today announced that Optometrics Corporation subsidiary signed a three-year comprehensive supply agreement with a division of L-3 Communications. Optometrics will be providing high-quality optical components under this agreement.

Gentor Announces Corporate and Board Appointments
Marketwire Canada - Fri Feb 14, 8:22AM CST
Gentor Resources Inc. ("Gentor" or the "Company") (TSX VENTURE:GNT) has made several corporate and board changes effective immediately. Arnold Kondrat, currently Executive Vice-President, has been appointed President and Chief Executive Officer of the Company replacing Dr. Peter Ruxton. Dr. Ruxton will continue as a director on the board of directors of the Company. "We would like to thank Peter for leading Gentor's exploration activities in Turkey and Oman and look forward to his continued support and technical expertise as a member of the board," commented Arnold Kondrat. Mr. Kondrat has been Executive Vice-President and a director of Gentor for the past 7 years. He has been involved in corporate finance activities for over 25 years. He is also President and Managing Director of Sterling Portfolio Securities Inc., a private venture capital firm based in Toronto. Mr. Kondrat is a founding director of Banro Corporation, Delrand Resources Limited and Loncor Resources Inc.

Dynasil Corporation of America Reports First Quarter Fiscal 2014 Financial Results
PR Newswire - Wed Feb 12, 6:50AM CST
Dynasil Corporation of America (NASDAQ: DYSL), a developer and manufacturer of optical detection and analysis technology and components for the homeland security, medical and industrial markets, today announced financial results for the fiscal 2014 first quarter ended December 31, 2013.

Research and Markets: Concise Analysis of the International Nitric Oxide Therapeutic Market - Updated 2014 Report
Business Wire - Thu Feb 06, 5:42AM CST
Research and Markets (http://www.researchandmarkets.com/research/jb88mn/nitric_oxide) has announced the addition of a new report "Concise Analysis of the International Nitric Oxide Therapeutic Market - Updated 2014 Report" to their offering.

Form 4: Update Filing for Dynasil Corporation Of America (DYSL)
Vickers Stock Research - Tue Feb 04, 6:11AM CST
THE WOODLANDS, TX, February 4, 2013 - Waste Connections, Inc. (NYSE: WCN) announced that it will report financial results for the fourth quarter of 2012 and outlook for the full year 2013 after the close of the stock market on February 20, 2013. The Company will be hosting an investor conference call related to this release on February 21st at 8:30 A.M. Eastern Time.

Domestic Nuclear Detection Office Awards Dynasil's RMD Unit $2.1 Million to Develop Next Generation Radiation Detection Equipment
PR Newswire - Thu Jan 23, 8:15AM CST
Dynasil Corporation of America (NASDAQ: DYSL) today announced that its RMD Research subsidiary has been awarded contracts totaling $2.1 million from the Department of Homeland Security's Domestic Nuclear Detection Office (DNDO). These contracts will advance the government's research and development initiatives focused on the identification of illicit nuclear materials.

Dynasil Regains Compliance with NASDAQ Listing Requirements
PR Newswire - Tue Jan 07, 1:00PM CST
Dynasil Corporation of America ("Dynasil" or the "Company") (NASDAQ: DYSL), a developer of sensing, detection and analysis technology for homeland security, medical and industrial applications, announced today that it has regained compliance with the $1.00 minimum bid price requirement for continued listing on the NASDAQ Capital Market.

Dilon Acquires RMD Navigator Gamma Probes
PR Newswire - Mon Jan 06, 9:17AM CST
Dilon Technologies Inc. announced today that they acquired the assets of the Navigator gamma probe business from RMD Instruments Corp., a subsidiary of Dynasil Corporation of America.

Dynasil Sells Navigator Product Line
PR Newswire - Tue Dec 24, 8:28AM CST
Dynasil Corporation of America (NASDAQ: DYSL), a developer of sensing, detection and analysis technology for homeland security, medical and industrial applications, today announced the December 23, 2013 sale of the assets of its Navigator Gamma Medical Probe product line to Dilon Technologies, Inc. of Newport News, Virginia.

Dynasil Corporation of America Reports Fiscal Year 2013 Financial Results
PR Newswire - Fri Dec 20, 3:35PM CST
Dynasil Corporation of America (NASDAQ: DYSL), a developer of sensing, detection and analysis technology for homeland security, medical and industrial applications, today announced financial results for fiscal year ended September 30, 2013 and the filing of its Annual Report on Form 10-K.

Accenture Completes Acquisition of PCO Innovation
CNW Group - Wed Dec 18, 12:12PM CST
Accenture (NYSE: ACN) has completed its acquisition of PCO Innovation - a leading independent international consulting and systems integration group that specializes in product lifecycle management (PLM) software technologies. The acquisition enhances Accenture's deep industry capabilities and the full range of services it provides clients in the design, building and management of systems and processes essential to driving their large-scale PLM transformation programs.

Dynasil's RMD Subsidiary Awarded $4 Million in Technology Development Grants by U.S. Department of Energy
PR Newswire - Tue Nov 19, 3:30PM CST
Dynasil Corporation of America (NASDAQ: DYSL) today announced that its contract research subsidiary, RMD Inc., has received four grants totaling $4.0 million under the U.S. Department of Energy's Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs.

Dynasil Divests XRF Product Line
PR Newswire - Thu Nov 07, 11:45AM CST
Dynasil Corporation of America (NASDAQ: DYSL), a developer of sensing, detection and analysis technology for homeland security, medical and industrial applications, today completed the sale of the assets of its X-Ray Florescence (XRF) Lead Paint Detector product line to PROTEC Instrument Corporation, the U.S. subsidiary of its long-time distributor, French firm Laboratories PROTEC S.A.

Dynasil Forms Xcede Technologies Inc.
PR Newswire - Thu Oct 10, 11:23AM CDT
Dynasil Corporation of America (NASDAQ: DYSL) today announced that Dynasil Biomedical Corp ("DBM") has established a new subsidiary, Xcede Technologies, Inc., and transferred patent pending biomaterials technology for use in tissue sealing and hemostasis. Xcede's technology is a ready-to-use high-strength, fast-acting, combination hemostat/ sealant. The Xcede Patch, the first embodiment of the technology that Xcede plans to commercialize, requires minimal preparation time (less than 1 minute), is not dependent on patient coagulation and is highly effective on aggressive bleeding. The technology was initially invented by Dr. Daniel Ericson and acquired by Dynasil in 2011. Since 2011 Dynasil has further developed and refined the technology within its subsidiary, DBM, before contributing it to Xcede.

OTC Daily Alert Stock Watch - Dynasil Corporation of America (NASDAQ: DYSL)
WorldStockWire - Fri Aug 30, 12:15AM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com

Dynasil Corporation of America Reports Third Quarter Fiscal 2013 Financial Results
PR Newswire - Mon Aug 12, 4:20PM CDT
Dynasil Corporation of America (NASDAQ: DYSL), a leading developer of sensing, detection and analysis technology for homeland security, medical and industrial applications, today announced financial results for the fiscal 2013 third quarter ended June 30, 2013.

Dynasil Corporation of America Reports Second Quarter Fiscal 2013 Financial Results
Business Wire - Wed May 15, 3:15PM CDT
Dynasil Corporation of America (NASDAQ: DYSL), a leading developer of sensing, detection and analysis technology for homeland security, medical and industrial applications, today announced financial results for the fiscal 2013 second quarter ended March 31, 2013.

Dynasil Corporation of America Elects Alan B. Levine to Board of Directors
Business Wire - Thu May 02, 8:00AM CDT
Dynasil Corporation of America (NASDAQ: DYSL), a leader in the development and manufacture of detection, sensing and analysis technology, today announced that Alan B. Levine was elected to a newly-created seat on the Board of Directors. Mr. Levine will serve as the chairman of the Audit Committee of the Board of Directors.

Dynasil Corporation of America drops to net loss of USD0.4m in Q1 fiscal 2013
M2 - Thu Feb 14, 3:15AM CST
Medical applications company Dynasil Corporation of America (NasdaqGM YSL) stated on Wednesday its net loss of USD0.4m (USD0.03 per share) for the fiscal 2013 first quarter ended 31 December 2012.

Dynasil Corporation of America (DYSL) Stock Research Links

DYSL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 13

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 18

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 19

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 24

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 20

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 24

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 15

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 19

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 19

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Inbank Reports Impressive Growth in Financial Performance

Updated Category News Views 237

Inbank's Stellar Financial Performance in Recent Quarters Inbank has achieved significant milestones in its Q2 2025 financial results, showcasing dynamic growth and resilience in a fluctuating market. The bank reported a remarkable originated volume of 196 million euros, marking a 15% increase from the previous year. Although consolidated net profit saw a slight decline...

Continue Reading
Navient Elects Edward Bramson as Chair After Shareholder Meeting

Updated Category News Views 164

Navient's Annual Meeting Marks a New Chapter HERNDON, Va. - Recently, Navient (Nasdaq: NAVI) convened its Annual Meeting of Shareholders, setting the stage for significant leadership changes within the company. This year, shareholders engaged actively, voting to approve three pivotal proposals outlined by the board of directors. This included the election of seven new...

Continue Reading
Annexon Secures $75 Million in Public Stock Offering

Updated Category News Views 184

Overview of Annexon's Recent Public Offering Annexon, Inc. (NASDAQ: ANNX), a pioneering biopharmaceutical firm, recently announced the successful pricing of its public offering aimed at raising $75 million. This exciting event took place as the company continues to push forward with its mission to address neuroinflammation and related diseases, facilitating groundbreaking...

Continue Reading
Werner Enterprises Set for Key Investment Conferences This Year

Updated Category News Views 310

Werner Enterprises is Poised for Investment Conference Engagements Werner Enterprises, Inc. (Nasdaq: WERN), a well-known name in transportation and logistics, is preparing to participate in several significant investment conferences. These events present a fantastic opportunity for the company to share insights about its growth strategies and market position. Upcoming...

Continue Reading
Cunard Achieves Unprecedented Booking Milestones in 2024

Updated Category News Views 156

Record-Breaking Booking Success for Cunard Cunard has recently announced remarkable booking figures for the year 2024, driven by a stellar year and the eagerly awaited introduction of its ship, Queen Anne. This significant increase has resulted in an astonishing 73,000 more guest reservations from January to October compared to the same timeframe in the previous year,...

Continue Reading